EP
MLNT

Eversept Partners’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Eversept Partners’s Portfolio MLNT Stock Details MLNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-5,296
Closed -$105K – 72
2018
Q3 		$105K Sell
5,296
-10,071
-66% -$199K 0.05% 57
2018
Q2 		$488K Hold
15,367
– – 0.22% 54
2018
Q1 		$569K Buy
+15,367
New +$569K 0.26% 47